Class II · ModerateRecall completed
Moxifloxacin Ophthalmic Solution
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot#: CMF210001, CMF210003, CMF210004, Exp 6/2023
Where it was soldUSA Nationwide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Impurities/Degradation Specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byMade in India foreign manufacturer
| Distributed by / for | Aurobindo Pharma USA, Inc., East Windsor, NJ 08520 |
| NDC | 65862-840-03 |
Show the full FDA record
| Full product label | Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03 |
| Recalling firm | Aurobindo Pharma USA Inc. |
| Distribution | USA Nationwide |
| Quantity | 115776 bottles |
| Recall initiated | 2022-01-14 |
| Report date | 2022-02-23 |
| Recall completed | 2024-07-31 |
| Recall number | D-0560-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | East Windsor NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.